Contract Research Outsourcing

Publication Date	October 2008
Publisher	Global Industry Analysts
Product Type	Report
Pages	455
ISBN Number	not applicable
Product Code	GIA00825

Buy this product or for assistance call +44 20 7060 7474

PDF £2,375.00$3951 | €2658

FAX Order above formats by FAX

Summary

This report analyzes the worldwide markets for Contract Research Outsourcing in Millions of US$. The major Service segments analyzed are Drug Discovery, and Clinical Research. The report provides separate comprehensive analytics for the US, Europe, Asia, and Rest of World. Annual forecasts are provided for each region for the period of 2000 through 2015. The report profiles 219 companies including many key and niche players worldwide such as Criterium, Inc., Covance, Inc., Encorium Group, Inc., ICON PLC, Covalent Group, Inc., Kendle, Life Sciences Research, Inc., MDS Pharma Services, MPI Research, Omnicare Clinical Research, Parexel International Corporation, PharmaNet Development Group, Inc., PRA International, Pharmaceutical Product Development, Inc., Quintiles Transnational Corporation, WIL Research Laboratories, LLC, Bio Analytical Research Corporation, Calvert Laboratories, Inc., CentraLabS Clinical Research, Charles River Laboratories, Inc., Huntingdon Life Sciences Research, Inc., Lab Research, Inc., Pacific Biometrics, Inc., Perry Scientific, Inc., Quest Diagnostics, Inc., SNBL USA, Ltd., DaVita Clinical Research, nTouch Research Corporation, PharmaTrials, Inc., Radiant Research, Inc., and Research Solutions, LLC. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.

Content

I. Introduction, Methodology & Product Definitions
- Study Reliability and Reporting Limitations
- Disclaimers
- Data Interpretation & Reporting Level
- Quantitative Techniques & Analytics
- Product Definitions and Scope of Study
II. Executive Summary
- 1. Industry Overview I
  - Background I
  - Growth and Transformation of CRO Industry I
  - Advantages of CRO for Pharmaceutical Companies I
  - Advantages of CRO for Clinical Research Organizations I
- 2. Industry Potential I
  - Outlook I
  - Competition Potential I
  - Regional Potential I
  - The United States I
  - Western Europe I
  - Central and Eastern Europe I
  - Asia-Pacific I
  - China I
  - India I
  - Latin America I
  - Service Potential I
  - Pre-Clinical Segment Gains Momentum I
  - Clinical Research - Encouraging Factors at Various Phases I
  - Phase I I
  - Phase II I
  - Phase III I
  - Phase IV I
  - Research & Development Potential I
  - Role of Technology in R&D I
- 3. Market Dynamics II-1
  - Challenges Faced by Contract Research Organizations II-1
  - on-shore versus Offshore CRO Business II-1
  - Cutthroat Competition among CROs II-1
  - Management of Production Capacities II-1
  - Management of Clinical Investigation II-1
  - Cost Containment II-1
  - Safety Concerns on Clinical Trials II-1
  - Pipeline Blocks II-1
  - Strategies and Tactical Programs for CROs II-1
  - Survival Strategies in Mature CRO Markets II-1
  - Exit from the Industry II-1
  - Expand Scale II-1
  - Capture Niche Segments II-1
  - Expand Geographically II-1
  - Strategies to Tap Opportunities in Growing Markets II-1
  - Mobilize Funds II-1
  - Expand Other Services II-1
  - Upgrade Technological and Knowledge Base II-1
  - Form Sub-Contracts or Regional Alliances II-1
  - Asia - Hub for Contract Research Outsourcing II-1
  - Overview II-1
  - Market Potential II-1
  - Activity Perspective II-1
  - Cost-Efficiency in Research and Development II-1
  - World-Class Clinical Trials II-1
  - Regional Perspective II-1
  - China II-1
  - Congenial Business Environment II-1
  - Compliance with Global CRO Standards II-1
  - Return of Skilled Human Resources II-1
  - Availability of Large Genetic Population II-1
  - Cost Advantages II-1
  - India II-1
  - Large Talent Pool of Human Resources II-1
  - Increased Regulatory Compliance II-1
  - Rich Genetic Diversity II-1
  - Cost-Savings and World-Class Quality II-1
  - Challenges in Outsourcing II-1
  - China II-1
  - Regulatory Hurdles II-1
  - Limited Funding Resources II-1
  - Demand War for Talented Personnel II-1
  - Teething problems II-1
  - Cultural and Language Difficulties II-1
  - India II-1
  - Restrictions on Clinical Trials II-1
  - Lack of Standardization II-1
  - Advantage India - hot spot for R&D investment II-1
  - Subject-compliance in major therapeutic areas II-1
  - Reliable Data Generation and Management II-1
  - Improved Base of Medical Infrastructure II-1
  - Strong Combination of CMOs and CROs II-1
  - Reverse-engineering Capabilities II-1
  - Market Trends II-1
  - Biotech Leads in CRO II-1
- 4. Recent Industry Activity II-1
  - Symyx Takes over Integrity Biosolution II-1
  - Worldwide Clinical Trials Acquires MediQuest II-1
  - BioImagene Launches a New CRO, AgilityBio II-1
  - Tigermed Receives Investments from Qiming II-1
  - Covance Inks MoU with WuXi for a Chinese Joint Venture II-1
  - Veeda Takes over International Oncology Network II-1
  - Kendle Acquires DecisionLine II-1
  - Encorium to Take over Prologue Research II-1
  - PharmaLinkFHI Takes over Matrix Contract Research Ltd. II-1
  - Encorium Receives Business Contracts for North America and Europe II-2
  - India's Jubilant Organosys to Takeover Draxis Health II-2
  - Shasun to Establish Process Development Unit in US II-2
  - Quintiles to Open Second Clinical Research Office in Wilmington II-2
  - LabCorp to Acquire Tandem Labs II-2
  - Shasun to Establish Process Development Unit in US II-2
  - MDS Pharma Expands in Latin America II-2
  - Iris Pharma and Clirophtha Merge to Form New Iris Pharma II-2
  - PPD to Acquire InnoPharm II-2
  - KCR Acquires DUX Consuling II-2
  - Cetero Research Acquires DGD Research II-2
  - Jubilant Organosys Acquires Hollister- Stier Laboratories II-2
  - Shasun Acquires Rhodia Pharma Plants II-2
  - Ocimum Biosolutions Acquires Gene Logic's Genomics Business II-2
  - Innovative Medical Device Sourcing Acquires Frontier BioMedical LLC II-2
  - UK-Based Premier Research Group PLC Acquires ARS, Inc. II-2
  - AAIPharma, Inc. Acquires Instituto de Pesquisa Clnica de So Paulo Ltda II-2
  - Covance to Renovate New Drug Development Facility in Virginia II-2
  - Covance Expands and Reshuffles Research Clinic II-2
  - Perceptive Informatics Alliance to Enhance Clinical Supply Chain Forecasting and Management II-2
  - Genstar Capital Acquires PRA International II-2
  - Covalent Acquires Remedium Oy and Changes Name to Encorium II-2
  - Quintiles Enters into a New Alliance with Washington County Hospital II-2
  - Kendle Expands in US and Europe II-2
  - Criterium Opens Two New Offices in Russia and Israel II-2
  - Premier Research Acquires Two Companies to Expand Product Offerings II-2
  - Averion Divests Staffing Services Segment II-2
  - Chiltern Acquires CTMS II-2
  - Quintiles Acquires Bio-Trials II-2
  - Parexel Acquires Apex International Clinical Research II-2
  - Charles River Forms Joint Venture with BioExplorer II-2
  - PAREXEL Opens New Location in India II-2
  - Avesthagen and Manipal Accunova Collaborate II-2
  - Matrix and ethica Clinical Research Form ethicamatrix II-2
  - Covance Opens Nutritional Chemistry Laboratory in Singapore II-2
  - MDS Pharma to Expand in European Market II-2
  - Vita Nova Acquires Sedoc II-2
  - Averion Acquires Hesperion II-2
  - Averion and BIOCANCER Form Strategic Alliance II-2
  - AstraZeneca Opens First CPU to Enhance Clinical Research in China II-2
  - AstraZeneca Acquires Biologics Manufacturing Facility II-2
  - AstraZeneca Inaugurates Global Process R&D Lab in Bangalore II-2
- 5. Focus on Key Players II-2
  - Contract Research Organizations II-2
  - Criterium, Inc. (US) II-2
  - Covance, Inc. (US) II-2
  - Encorium Group, Inc. (US) II-2
  - ICON PLC (Ireland) II-2
  - Kendle (US) II-2
  - Life Sciences Research, Inc. (US) II-2
  - MDS Pharma Services (US) II-2
  - MPI Research (US) II-2
  - Omnicare Clinical Research (US) II-3
  - Parexel International Corporation (US) II-3
  - PharmaNet Development Group, Inc. (US) II-3
  - PRA International (US) II-3
  - Pharmaceutical Product Development, Inc. (US) II-3
  - Quintiles Transnational Corporation (US) II-3
  - WIL Research Laboratories, LLC (US) II-3
  - Preclinical Laboratories II-3
  - Bio Analytical Research Corporation (US) II-3
  - Calvert Laboratories, Inc. (US) II-3
  - CentraLabS Clinical Research (US) II-3
  - Charles River Laboratories, Inc. (US) II-3
  - Huntingdon Life Sciences Research, Inc. (UK) II-3
  - Laboratory Corporation of America Holdings (US) II-3
  - Lab Research, Inc. (Canada) II-3
  - Pacific Biometrics, Inc. (US) II-3
  - Perry Scientific, Inc. (US) II-3
  - Quest Diagnostics, Inc. (US) II-3
  - SNBL USA, Ltd. (US) II-3
  - Site Management Organizations II-3
  - DaVita Clinical Research (US) II-3
  - nTouch Research Corporation (US) II-3
  - PharmaTrials, Inc. (US) II-3
  - Radiant Research, Inc. (US) II-3
  - Research Solutions, LLC (US) II-3
- 6. Global Market Perspective II-3
III. Market
- 1. The United States II
  - A. Market Analysis II
    - Largest Market Worldwide II
    - Competitive Scenario II
    - Recent Industry Activity II
    - Focus on Key Players II
    - Contract Research Organizations II
    - Preclinical Laboratories II
    - Site Management Operations III-1
  - B. Market Analytics III-1
- 2. Europe III-1
  - A. Market Analysis III-1
    - Significant Market in Contract Research Outsourcing III-1
    - Market Overview III-1
    - Competitive Scenario III-1
    - Eastern Europe - Center for Clinical Trials III-1
    - Recent Industry Activity III-1
    - Select Players III-1
    - ClinTec International Ltd. - A British CRO III-1
    - ICON PLC - An Irish CRO III-1
    - Huntingdon Life Sciences Research, Inc.- A UK-based Preclinical Laboratory III-1
  - B. Market Analytics III-1
- 3. Asia III-2
  - A. Market Analysis III-2
    - Promising Market III-2
    - Outsourcing Destinations: China and India III-2
    - Promoting Role of the Government III-2
    - Focus on Key Markets III-2
    - India III-2
    - A Thriving Clinical Trial Market III-2
    - Reasons for Outsourcing to India III-2
    - List of Pharmaceutical Companies Outsourcing Clinical Research to India III-2
    - SWOT Analysis III- III-2
    - Competitive Scenario III-2
    - Regulatory Environment III-2
    - Major Contract Research Organizations III-2
    - Ace Biomed Pvt. Ltd. III-2
    - Asian Clinical Trials Limited III-2
    - Catalyst Clinical Services Pvt. Ltd. III-2
    - Clinigene International Limited III-2
    - ClinInvent Research Pvt. Ltd. III-2
    - Clintrac International Pvt. Ltd. III-2
    - Clinsys Clinical Research, Inc. III-2
    - Lotus Labs Pvt. Ltd. III-2
    - Nicholas Piramal India Limited. III-2
    - Shasun Chemicals & Drugs Limited III-2
    - SIRO Clinpharm Pvt. Ltd. III-2
    - Vimta Labs III-2
    - China III-2
    - Factors Favoring Outsourcing to China III-2
    - SWOT Analysis III-2
    - Policies Governing Clinical Trials in China III-2
    - Clinical Research Market Size III-3
    - Select Contract Research Organizations III-3
    - Astrom Research International III-3
    - Atuka Ltd. III-3
    - Excel PharmaStudies Inc. III-3
    - Gleneagles Clinical Research Center (Singapore) III-3
    - Japan III-3
    - Recent Industry Activity III-3
  - B. Market Analytics III-3
- 4. Rest of World III-3
  - A. Market Analysis III-3
    - Recent Industry Activity III-3
  - B. Market Analytics III-3
IV. Competitive Landscape
List of Tables
- Table 1: Number of Clinical Trials Worldwide (2000-2007) (includes corresponding Graph/Chart) I
- Table 2: Percentage Breakup of Number of Pipeline Drugs Worldwide by Phase- Preclinical, Phase I, Phase II, Phase III and Phase IV (2007) (includes corresponding Graph/Chart) I
- Table 3: Percentage Breakup of Life Sciences Revenues (FY 2007) of Major Players by Service Type- Preclinical, Phase I, Phase IIA, Phase IIB, Phase III, Phase IIIb/IV, Central Lab, Bioanalytical and Others I
- Table 4: Global CRO Market (2007): Number of CROs by Service Type- Phase I, Phase I-IV, Data Management Services (DMS), Regulatory Affairs, Quality Analysis (QA), Preclinical /Toxicology and Lab Analysis (includes corresponding Graph/Chart) I
- Table 5: Global Pre-clinical CRO Market (2007): Percentage Breakup of Market Share Based on Revenues for Charles River Labs, Covance, Life Science Research, MPI Research, SNBL USA, WIL Research Labs, MDS, LAB Research and Others (includes corresponding Graph/Chart) I
- Table 6: Leading Biotechnology and Pharmaceutical Research Companies Worldwide - Ranked by Year 2006 Revenues in US$ Million (includes corresponding Graph/Chart) I
- Table 7: Percentage Breakup of Global R&D Spending by Region (2008E) (includes corresponding Graph/Chart) I
- Table 8: Percentage Breakup of Global R&D Spending by Market (2005-2010) (includes corresponding Graph/Chart) I
- Table 9: Cost of Conducting Clinical Trials: India vs US (in US$ Million) (includes corresponding Graph/Chart) II-1
- Table 10: World Recent past, Current and Future Analysis for Contract Research Outsourcing by Geographic Region - US, Europe, Asia and Rest of World Independently Analyzed by Annual Revenues in US$ Million for the Years 2000-2010 (includes corresponding Graph/Chart) II-3
- Table 11: World Long-Term Projections for Contract Research Outsourcing by Geographic Region - US, Europe, Asia and Rest of World Independently Analyzed by Annual Revenues in US$ Million for the Years 2011-2015 (includes corresponding Graph/Chart) II-3
- Table 12: World 10-Year Perspective for Contract Research Outsourcing by Geographic Region - Percentage Breakdown of Revenues for US, Europe, Asia and Rest of World for the Years 2003, 2008 and 2012 (includes corresponding Graph/Chart) II-3
- Table 13: World Recent past, Current and Future Analysis for Contract Research Outsourcing for Drug Discovery by Geographic Region - US, Europe, Asia and Rest of World Independently Analyzed by Annual Revenues in US$ Million for the Years 2000-2010 (includes corresponding Graph/Chart) II-4
- Table 14: World Long-Term Projections for Contract Research Outsourcing for Drug Discovery by Geographic Region - US, Europe, Asia and Rest of World Independently Analyzed by Annual Revenues in US$ Million for the Years 2011-2015 (includes corresponding Graph/Chart) II-4
- Table 15: World 10-Year Perspective for Contract Research Outsourcing for Drug Discovery by Geographic Region - Percentage Breakdown of Revenues for US, Europe, Asia and Rest of World for the Years 2003, 2008 and 2012 (includes corresponding Graph/Chart) II-4
- Table 16: World Recent past, Current and Future Analysis for Contract Research Outsourcing for Clinical Research by Geographic Region - US, Europe, Asia and Rest of World Independently Analyzed by Annual Revenues in US$ Million for the Years 2000-2010 (includes corresponding Graph/Chart) II-4
- Table 17: World Long-Term Projections for Contract Research Outsourcing for Clinical Research by Geographic Region - US, Europe, Asia and Rest of World Independently Analyzed by Annual Revenues in US$ Million for the Years 2011-2015 (includes corresponding Graph/Chart) II-4
- Table 18: World 10-Year Perspective for Contract Research Outsourcing for Clinical Research by Geographic Region - Percentage Breakdown of Revenues for US, Europe, Asia-Pacific and Rest of World for the Years 2003, 2008 and 2012 (includes corresponding Graph/Chart) II-4
- Table 19: US CRO Market (2007): Percentage Breakdown of CRO Revenues by Player Category (includes corresponding Graph/Chart) II
- Table 20: US Recent past, Current and Future Analysis for Contract Research Outsourcing by Service Segment - Drug Discovery and Clinical Research Independently Analyzed by Annual Revenues in US$ Million for the Years 2000- 2010 (includes corresponding Graph/Chart) III-1
- Table 21: US Long-Term Projections for Contract Research Outsourcing by Service Segment - Drug Discovery and Clinical Research Independently Analyzed by Annual Revenues in US$ Million for the Years 2011-2015 (includes corresponding Graph/Chart) III-1
- Table 22: US 10-Year Perspective for Contract Research Outsourcing by Service Segment - Percentage Breakdown of Revenues for Drug Discovery and Clinical Research for the Years 2003, 2008 and 2012 III-1
- Table 23: European Recent past, Current and Future Analysis for Contract Research Outsourcing by Service Segment - Drug Discovery and Clinical Research Independently Analyzed by Annual Revenues in US$ Million for the Years 2000-2010 (includes corresponding Graph/Chart) III-1
- Table 24: European Long-Term Projections for Contract Research Outsourcing by Service Segment - Drug Discovery and Clinical Research Independently Analyzed by Annual Revenues in US$ Million for the Years 2011-2015 (includes corresponding Graph/Chart) III-2
- Table 25: European 10-Year Perspective for Contract Research Outsourcing by Service Segment - Percentage Breakdown of Revenues for Drug Discovery and Clinical Research for the Years 2003, 2008 and 2012 III-2
- Table 26: CRO Market Size (US$ million) for Clinical Research in Asia (2004 - 08) (includes corresponding Graph/Chart) III-2
- Table 27: Indian CRO Market Revenues in US$ Million (2003-2010) (includes corresponding Graph/Chart) III-2
- Table 28: Cost of Conducting Clinical Trials: India vs US (in US$ Million) (includes corresponding Graph/Chart) III-2
- Table 29: CRO Market Size (US$ million) for Clinical Research in China (2004 - 08) (includes corresponding Graph/Chart) III-3
- Table 30: Japanese CRO Market (2007): Percentage Breakdown of Value Sales by Segment- Clinical, Devices, Food & Supplement, SMO/CRC, Pre-Clinical and Others (includes corresponding Graph/Chart) III-3
- Table 31: Asian Recent past, Current and Future Analysis for Contract Research Outsourcing by Service Segment - Drug Discovery and Clinical Research Independently Analyzed by Annual Revenues in US$ Million for the Years 2000-2010 (includes corresponding Graph/Chart) III-3
- Table 32: Asian Long-Term Projections for Contract Research Outsourcing by Service Segment - Drug Discovery and Clinical Research Independently Analyzed by Annual Revenues in US$ Million for the Years 2011-2015 (includes corresponding Graph/Chart) III-3
- Table 33: Asian 10-Year Perspective for Contract Research Outsourcing by Service Segment - Percentage Breakdown of Revenues for Drug Discovery and Clinical Research for the Years 2003, 2008 and 2012 III-3
- Table 34: Rest of World Recent past, Current and Future Analysis for Contract Research Outsourcing by Service Segment - Drug Discovery and Clinical Research Independently Analyzed by Annual Revenues in US$ Million for the Years 2000-2010 (includes corresponding Graph/Chart) III-3
- Table 35: Rest of World Long-Term Projections for Contract Research Outsourcing by Service Segment - Drug Discovery and Clinical Research Independently Analyzed by Annual Revenues in US$ Million for the Years 2011-2015 (includes corresponding Graph/Chart) III-4
- Table 36: Rest of World 10-Year Perspective for Contract Research Outsourcing by Service Segment - Percentage Breakdown of Revenues for Drug Discovery and Clinical Research for the Years 2003, 2008 and 2012 III-4